Study says removal of pancreas can help in controlling diabetes

By Admin
The researchers from the Mayo Clinic have discovered that after the removal of the entire pancreas, the patients can manage their diabetes. The symptom...

The researchers from the Mayo Clinic have discovered that after the removal of the entire pancreas, the patients can manage their diabetes.

The symptoms for diabetes are hunger and weight loss, but with the diagnosis of this disease it can sometimes become difficult to manage.

Prior to the procedure, the patients were found to have cancer or precancerous cysts in the pancreas. The researchers’ focused their attention on looking at how the patients could control their diabetes following the surgeries that will take out their entire pancreas.

The study was recently featured in the journal HPB Surgery. The study believes that findings show that removing the entire pancreas has effective and safe results.

In the study, a total of 14 patients participated and the researchers looked at the control of insulin for over a number of years.

The findings were compared with 100 people with type 1 diabetes who utilized insulin replacements. Both the groups displayed little difficulty in managing blood sugar but no complications took place.  

According to Dr. Michael Wallace, Chair of the Division of Gastroenterology and Hepatology at Mayo Clinic, “What we have show here is that, due to wonderful recent improvements in insulin therapy, patients with a pancreas can control their blood sugar as effectively as type 1 diabetes patients can.”

On the whole, the findings reflect the experiences of the patients who are at the Mayo Clinic.

Share

Featured Articles

UnitedHealth CEO Admits Hack hit Third of US Citizens' Data

UnitedHealth Group CEO Andrew Witty tells stunned US congressional hearing Change Healthcare cyberattack affects third of the US population

Why Sanofi Leads the way on Healthcare Sustainability

How French multinational Sanofi is ensuring delivery of essential medical supplies while being ESG-compliant

Philips Q1 Results hit by $1.1bn Respironics Settlement

As Royal Philips reports Q1 2024 results we profile the Netherlands-based healthcare technology company, who made the switch from consumer electronics

Vaccine Breakthrough on Antibiotics Resistant Diseases

Medical Devices & Pharma

Oracle Fusion Cloud Update Boost for Patients

Technology & AI

WHO Tightens air Quality Guidelines as Pollution Kills 7mn

Sustainability